Will The Money Keep Rolling?: Innovative Global Health Financing And Governance26/05/2017 by Mara Pillinger for Health Policy Watch Leave a CommentShare this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Google+ (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)We are in a liminal moment for global health financing. The “golden age” of increasing donor funding is clearly over, arrested by the 2008 financial crisis. But while donor contributions are no longer climbing, they have not been falling, either. And it is possible this status quo will hold… But it’s equally possible that this is just the pause before the roller-coaster drops. Considering that Gavi, the Global Fund, and the World Bank will all be launching another replenishment round in 2019—and given the uncertainty surrounding US foreign aid commitments and post-polio financing—that drop may prove very steep indeed. On 23 May, the Global Health Centre at the Graduate Institute convened a panel to discuss how global health financing is changing. The speakers represented a range of perspectives, from international organizations (Tim Evans, Senior Director of Health, Nutrition and Population at the World Bank); major global health partnerships (Santiago Cornejo, Director of Immunization, Financing & Sustainability, Country Programs at Gavi (Harley Feldbaum, Head of Policy and Strategy at the Global Fund); donor governments (Hendrik Schmitz Guinote, Counsellor at the Permanent Mission of the Federal Republic of Germany in Geneva); and Global South governments (Susie Perera, Deputy Director General for Planning at the Sri Lankan Ministry of Health). Here are four key takeaways that emerged:1) If programs are successful, there’s no cause for panic…yetFor now, donor funding is holding steady (with the possible troubling exception of the US). Harley Feldbaum, from the Global Fund, pointed out that “donors’ agreement to fund effective global health interventions has proven really durable.” For example, while the percentage of funding coming from non-G7 countries and private donors has increased slightly in recent years, the G7 still account for 78% of Global Fund contributions. And Gavi, the Global Fund, and the World Bank have all undergone successful replenishments post-crisis. Santiago Cornejo, from Gavi, echoed this point, saying Gavi’s record replenishment in 2015 “shows that, at the end of the day, value for money and results will bring the money [in].”But Feldbaum admits that the pressure to continue demonstrating results is what keep him up at night. Tim Evans, from the World Bank, recognized a similar pressure. The first key component of the Bank’s strategy is “smarter [programs]”. Programs need to be able to demonstrate efficiency and better use of resources all along the way, from allocation to implementation to financial management. According to Evans, when speaking “with Ministries of Finance [about funding], if you can’t make the case that you’re using [your] existing resources well, there is no more discussion.”2) Transitions are hard, but the level of concern is disproportionateFrom the start, Global Fund and Gavi support was designed to be catalytic and temporary—something that countries would wean off of as GNIs [gross national incomes] and self-financing capacity increased. However, as a growing number of countries become ineligible, observers have raised concerns about the pace of change and whether governments have allocated sufficient resources and mustered the political will to maintain programs post-transition. Both organizations acknowledged the complexities and challenges of transition, especially for countries that face a loss of funding from multiple bilateral and multilateral donors at the same time.Yet the speakers also implied that the level of anxiety about transitions is disproportionate to the magnitude of their impact. According to Feldbaum, the Global Fund currently has only 12 “components” (receiving $35 million total) in transition. In contrast, 92% of Global Fund grants (about $9.4 billion) goes to low-income countries, which are “not even close” to transition. Gavi projects that 19 countries will exceed the eligibility threshold in the 2016-2020 period. But Cornejo explains that since 2008, Gavi has implemented a mandatory self-financing model, in which all countries contribute at least a small amount to the cost of their programs. As GNI rises, countries’ co-financing requirement gradually increases; by the time Gavi financing ends, they are already self-financing most of their programs.3) Domestic financing is the future On this, the panelists were emphatically unanimous. In what Tim Evans calls a “big awakening”, donors have come to realize that “there isn’t anything that development assistance [for health (DAH)] alone can do”. The essential strategic question for the Bank isn’t how to get more donor funding, it’s “how do we use DAH to support the mobilization of domestic resources.” Evans points out that DAH only accounts for a small percentage of the total amount of money spent on health in developing countries. The majority of that money comes from private, pay-as-you-go financing, which is “the worst” approach. Going forward, donors’ most valuable contributions will be in the form of technical assistance and capacity building (e.g. assisting governments in strengthening national financing plans or bolstering pooled procurement mechanisms so that national funds can be used more efficiently). By way of example, Hendrik Schmitz Guinote described Germany’s bilateral and multilateral efforts to help countries develop national health strategies.Sri Lanka exemplifies both the progressive changes and the challenges that panelists expect to see. Susie Perera reported that external donor support accounts for only 5% of the country’s total health expenditures. In the past, Sri Lanka received support from Gavi and from the Global Fund for all three diseases. Now, immunization programs are fully financed by the government (with the exception of a “small amount” of support from UNICEF); HIV and TB spending are still supported by the Global Fund, but malaria has been eliminated.As Perera explains, the Ministry of Health was able to achieve this “by being precise in estimating our requirements and in budget forecasting, and by using a competitive bidding process for procurement.”But Sri Lanka is also facing a new set of challenges. Despite a general tax-based financing system and the government’s commitment to provide free care at point of delivery, out-of-pocket expenditures still account for 42% of all health spending. The country currently spends about 1.5% of GDP on health, but is now having trouble stretching that to address non-communicable diseases. The Ministry plans to free up additional funds by curtailing investments in infrastructure and reorganizing primary health care services, but whether this will be enough is an open question.4) Now please turn your attention to systems strengthening For Perera, Sri Lanka’s experience demonstrates the importance of strengthening national health systems, not only in terms of healthcare delivery but also in terms of management and organization. Evans argued that financing also needs to become more systematic. Disease-specific approaches, whether in the form of donor programs or sin taxes, are outdated. And according to Guinote, donors also want to see a more coordinated approach at the international level to prevent fragmentation, duplication, and overburdened aid budgets. In other words, try to avoid having the Global Fund, Gavi, and World Bank replenishments all in the same year.Mara Pillinger is a PhD candidate at George Washington University. Follow her on Twitter @mplngr. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Google+ (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)RelatedMara Pillinger may be reached at ."Will The Money Keep Rolling?: Innovative Global Health Financing And Governance" by Health Policy Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.